Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Japanese (NIKKEI) Pharma Industry Analysis

UpdatedApr 27, 2026
DataAggregated Company Financials
Companies41
  • 7D-1.6%
  • 3M0.8%
  • 1Y17.2%
  • YTD2.0%

Over the last 7 days, the Pharma industry has dropped 1.6%, driven by Chugai Pharmaceutical declining 16%. In the past year, the industry has gained 17%. Earnings are forecast to grow by 8.9% annually.

Industry Valuation and Performance

Has the Japanese Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Mon, 27 Apr 2026JP¥48.0tJP¥17.3tJP¥2.2t15x21.9x2.8x
Wed, 25 Mar 2026JP¥48.7tJP¥17.3tJP¥2.2t15.4x22.3x2.8x
Fri, 20 Feb 2026JP¥52.2tJP¥17.3tJP¥2.2t15.9x23.9x3x
Sun, 18 Jan 2026JP¥47.0tJP¥16.9tJP¥1.9t16.7x24.6x2.8x
Tue, 16 Dec 2025JP¥46.2tJP¥16.9tJP¥1.9t15.8x24.3x2.7x
Thu, 13 Nov 2025JP¥43.2tJP¥16.9tJP¥1.9t15.3x22.5x2.6x
Sat, 11 Oct 2025JP¥42.5tJP¥16.8tJP¥1.8t15.4x23.3x2.5x
Mon, 08 Sep 2025JP¥41.6tJP¥16.8tJP¥1.8t16.2x22.8x2.5x
Wed, 06 Aug 2025JP¥41.1tJP¥16.8tJP¥1.8t16.8x22.3x2.4x
Fri, 04 Jul 2025JP¥39.2tJP¥16.8tJP¥1.8t14.9x22.3x2.3x
Sun, 01 Jun 2025JP¥41.3tJP¥16.8tJP¥1.8t14.8x23.3x2.4x
Tue, 29 Apr 2025JP¥40.6tJP¥16.7tJP¥1.7t15x24x2.4x
Thu, 27 Mar 2025JP¥41.0tJP¥16.5tJP¥1.5t16.1x27.3x2.5x
Sat, 22 Feb 2025JP¥40.4tJP¥16.5tJP¥1.5t15.8x26.9x2.5x
Mon, 20 Jan 2025JP¥40.2tJP¥16.1tJP¥1.4t15.4x28.6x2.5x
Wed, 18 Dec 2024JP¥41.7tJP¥16.1tJP¥1.4t14.8x29.6x2.6x
Fri, 15 Nov 2024JP¥43.8tJP¥16.1tJP¥1.4t15.2x30.9x2.7x
Sun, 13 Oct 2024JP¥44.9tJP¥15.6tJP¥1.2t15.9x37.4x2.9x
Tue, 10 Sep 2024JP¥45.6tJP¥15.5tJP¥1.2t17.6x38x2.9x
Thu, 08 Aug 2024JP¥43.6tJP¥15.5tJP¥1.2t16x36.3x2.8x
Sat, 06 Jul 2024JP¥43.9tJP¥15.0tJP¥1.1t18.5x40.1x2.9x
Mon, 03 Jun 2024JP¥40.9tJP¥15.0tJP¥1.1t17x37.3x2.7x
Wed, 01 May 2024JP¥41.1tJP¥14.9tJP¥1.2t19x33.3x2.8x
Fri, 29 Mar 2024JP¥42.1tJP¥15.1tJP¥1.2t19.7x34.7x2.8x
Sun, 25 Feb 2024JP¥42.1tJP¥15.1tJP¥1.2t20.6x34.6x2.8x
Tue, 23 Jan 2024JP¥41.3tJP¥15.2tJP¥1.4t19.8x30x2.7x
Thu, 21 Dec 2023JP¥38.9tJP¥15.2tJP¥1.4t19.3x28.3x2.6x
Sat, 18 Nov 2023JP¥39.1tJP¥15.2tJP¥1.4t19.9x28.4x2.6x
Mon, 16 Oct 2023JP¥39.8tJP¥14.9tJP¥1.4t24x27.9x2.7x
Wed, 13 Sep 2023JP¥41.0tJP¥14.9tJP¥1.4t24.1x28.7x2.7x
Fri, 11 Aug 2023JP¥40.5tJP¥14.9tJP¥1.4t22.9x28.4x2.7x
Sun, 09 Jul 2023JP¥38.3tJP¥14.6tJP¥1.5t20.2x26.2x2.6x
Tue, 06 Jun 2023JP¥40.9tJP¥14.6tJP¥1.5t19.9x28x2.8x
Thu, 04 May 2023JP¥39.2tJP¥14.5tJP¥1.4t18.7x27.6x2.7x
Price to Earnings Ratio

27.6x


Total Market Cap: JP¥39.2tTotal Earnings: JP¥1.4tTotal Revenue: JP¥14.5tTotal Market Cap vs Earnings and Revenue0%0%0%
Japanese Pharma Industry Price to Earnings3Y Average 28.6x202420252026
Current Industry PE
  • Investors are pessimistic on the Japanese Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 21.9x which is lower than its 3-year average PE of 28.6x.
  • The industry is trading close to its 3-year average PS ratio of 2.7x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have grown 16% per year over the last three years.
  • Revenues for these companies have grown 6.0% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Japanese Healthcare industry?

JP Market-0.95%
Healthcare-2.03%
Pharma-1.63%
Pharma-1.63%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
4506 Sumitomo PharmaJP¥1.94k-6.7%
JP¥44.4b		181.7%PE7.9x
4886 ASKA Pharmaceutical HoldingsLtdJP¥2.91k2.0%
+JP¥1.6b		25.7%PE16.9x
4539 Nippon ChemipharJP¥1.73k2.4%
+JP¥144.3m		17.8%PE11.4x

Latest News

4503
JP¥2,385.50
Astellas Pharma
7D
-7.2%
1Y
66.2%
4519
JP¥7,445.00
Chugai Pharmaceutical
7D
-15.8%
1Y
-7.1%
4151
JP¥2,318.50
Kyowa Kirin
7D
-6.1%
1Y
5.6%
4507
JP¥3,075.00
Shionogi
7D
-4.3%
1Y
27.9%
4568
JP¥2,602.50
Daiichi Sankyo Company
7D
-13.3%
1Y
-25.9%

4568: Broad Oncology Pipeline And Buyback Progress Will Support A Higher Future Market Rating

Analysts have reduced their price target on Daiichi Sankyo Company from about ¥3,623 to roughly ¥3,065, citing updated assumptions that pair lower expected revenue growth with a slightly higher profit margin outlook and a more restrained future P/E of around 20x. What's in the News The share buyback program was completed, with 31,457,200 shares repurchased for ¥91,846.79 million, representing 1.7% of shares, under the authorization announced on April 25, 2025 (Key Developments).
4506
JP¥1,935.00
Sumitomo Pharma
7D
-6.7%
1Y
181.7%
4523
JP¥4,570.00
Eisai
7D
-6.9%
1Y
12.1%
4886
JP¥2,912.00
ASKA Pharmaceutical HoldingsLtd
7D
2.0%
1Y
25.7%
4502
JP¥5,218.00
Takeda Pharmaceutical
7D
-6.4%
1Y
21.5%

4502: Fair Outlook Will Depend On Late Stage Pipeline And Legal Outcomes

Analysts have adjusted their price target on Takeda Pharmaceutical from about ¥5,697 to roughly ¥6,004, reflecting updated assumptions around revenue growth, profit margins, and future P/E expectations. What's in the News Takeda plans a leadership transition, with current CEO Christophe Weber set to retire at the 150th Ordinary General Meeting of Shareholders on June 24, 2026.
4528
JP¥2,304.50
Ono Pharmaceutical
7D
-5.1%
1Y
39.6%
4539
JP¥1,726.00
Nippon Chemiphar
7D
2.4%
1Y
17.8%